What is ENDV's health score?

ENDONOVO THERAPEUTICS, INC. (ENDV) has a TradeApes health score of 45 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ENDV's estimated fair value?

Based on our 5-year discounted cash flow model, ENDONOVO THERAPEUTICS, INC.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ENDV undervalued or overvalued?

Our model currently rates ENDV as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

1 free score card remaining

ENDONOVO THERAPEUTICS, INC. (ENDV)

Healthcare Inconclusive inconclusive mixed

$0.0

Updated: 2026-07-14

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

55 Mixed

Relative Value

40 Weak

Capital Allocation

30 Weak

Risk Management

50 Mixed

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees

Unlock Full Report →

Industry Related Stocks

Adagio Medical Holdings, Inc. (ADGM) ADM TRONICS UNLIMITED, INC. (ADMT) AETHLON MEDICAL INC (AEMD) Axe Compute Inc. (AGPU) ALIGN TECHNOLOGY INC (ALGN) ALLURION TECHNOLOGIES, INC. (ALUR)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.